Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia.
about
Neuroinflammation and psychiatric illnessEarly interventions in risk groups for schizophrenia: what are we waiting for?Molecular substrates of schizophrenia: homeostatic signaling to connectivitySocial isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneuronsCuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.Oxidative stress and schizophrenia: recent breakthroughs from an old storyInflammatory molecular signature associated with infectious agents in psychosis.Causes of metabolic syndrome and obesity-related co-morbidities Part 1: A composite unifying theory review of human-specific co-adaptations to brain energy consumption.Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophreniaIn vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma.Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia.Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence.Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.Psychiatric disorders biochemical pathways unraveled by human brain proteomics.Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatryGenetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early PsychosisOxidative/Nitrosative stress in psychiatric disorders: are we there yet?Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry.N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.Chronic phencyclidine induces inflammatory responses and activates GSK3β in mice.Autoimmune phenotypes in schizophrenia reveal novel treatment targets.
P2860
Q21245244-84B89713-C757-4051-B37B-177B7770C648Q26747545-2A4F789C-1A3B-40C4-A3FE-5BC29B0BF332Q30383611-B20414A0-9F78-4A9C-B83F-0B1342722181Q30438450-D8BF5734-459E-403A-B46E-C71DD5553629Q30442608-ABF2C614-9EDB-4B8D-80C1-3E9C20AA0695Q30774039-25A51EF3-666B-462A-9184-8D5C9DD2F6CDQ34048637-0A1C76B1-24D8-4A99-9905-E12E8C4332CEQ35104481-0EEB57C5-51AF-43F2-AE10-50D15EBE313FQ35872055-1A420290-2BF9-41E7-A00F-3BB99E90CDCEQ36915357-2D0A541A-8DE1-4007-B7C0-0E428DC7CE04Q37139004-36B9E350-9F05-4739-8C8A-ED1A2208FDE0Q38739624-261B25A4-EBF7-496D-837D-D9C80A4A5358Q38809444-AF93D3DA-0187-416F-B2FF-3E374FF683C3Q38885740-42C76AD5-2165-4891-9688-015434892F0CQ40369760-F1CDF631-87A5-4B98-B572-61F11644B7FDQ41687474-1F16899D-626F-48F1-BD32-60D169BB8BDAQ41703320-EC063B3A-FFA7-4C40-88E1-437BCFD47504Q42792118-A5FBC932-7FAE-4AFD-8B0D-2EE91131F5B9Q47331971-B778DF4B-75B9-41AC-8289-C98A8B9622EBQ50281040-C60A1942-7393-4736-A8CF-1C423C725BC3Q50778063-124EACE2-190A-4906-9554-20FB64BC91A8Q54217096-AE551A10-3502-4A35-B3F5-9D2C171FFDA9
P2860
Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Marked reduction of soluble su ...... th recent-onset schizophrenia.
@ast
Marked reduction of soluble su ...... th recent-onset schizophrenia.
@en
type
label
Marked reduction of soluble su ...... th recent-onset schizophrenia.
@ast
Marked reduction of soluble su ...... th recent-onset schizophrenia.
@en
prefLabel
Marked reduction of soluble su ...... th recent-onset schizophrenia.
@ast
Marked reduction of soluble su ...... th recent-onset schizophrenia.
@en
P2093
P2860
P50
P356
P1433
P1476
Marked reduction of soluble su ...... ith recent-onset schizophrenia
@en
P2093
F T Seifuddin
J A Edwards
K Ishizuka
M A Shimano
M G Pomper
N G Cascella
R H Yolken
P2860
P2888
P356
10.1038/MP.2012.6
P407
P577
2012-02-21T00:00:00Z